Edge Medical Co., Ltd.

What Edge Medical Co., Ltd. does

Edge Medical Co., Ltd. (深圳市精锋医疗科技股份有限公司) is a Shenzhen-headquartered surgical robotics company that designs, develops, and manufactures integrated minimally invasive surgical platforms. Founded in 2016 and listed on the Hong Kong Stock Exchange on January 8, 2026, the company has built a portfolio across four core products: the Edge Multi-Port Endoscopic Surgical Robot, the Edge Single-Port Endoscopic Surgical Robot (a single-arm, single-port system with all instruments passing through one trocar), the EdgeCloud Telesurgery System (a second-generation TS02 platform supporting dual-console collaboration and cross-border remote surgery), and the Edge Bronchoscopic Robot (CP1000, China's first dual-arm bronchoscopy robot integrating electromagnetic navigation, radial ultrasound, and CBCT positioning). It was the first company in China to receive NMPA registration approvals for multi-port, single-port, and natural orifice surgical robots, and in March 2026 secured NMPA approval for the '3-in-1' integrated platform combining multi-port, single-port, and telesurgery on a unified architecture.

The platform combines high-definition 3D visualization, articulating wristed instruments, dual-console collaborative operation, multimodal ultrasound picture-in-picture, an in-house fluorescence imaging system, and telesurgery capabilities with demonstrated round-trip latencies as low as 52ms and intercontinental transmissions (e.g., Rome-to-Beijing, ~8,200 km at 143ms). Edge Medical earned the EU CE MDR for its multi-port system in March 2025 and CE certification for its single-port system in October 2025, extending market access beyond China.

The business model is enterprise B2B hardware sales combined with professional services: surgical robot systems (including instrument packs and accessories) are sold directly to leading hospitals and academic medical centers, with clinical support teams providing installation, intraoperative assistance, training, and ongoing technical service. International expansion uses a hybrid model — direct sales to flagship hospitals (e.g., Zhujiang Hospital with 1,600+ procedures, SIUT Pakistan with 470+ procedures, Pro-Familia Poland with 200+ procedures) supplemented by regional distribution partners such as IDS Medical Systems in Southeast Asia and Oncorad in Morocco, plus the ORSI Academy for European clinical training. Customer segments are predominantly large tertiary and academic hospitals spanning China, Europe, South Asia, Southeast Asia, Latin America, and Africa, with urology as the primary surgical specialty and emerging expansion into gynecology, general surgery, thoracic surgery, and head and neck surgery. FY2025 revenue was 456 million RMB (185% YoY growth) at a 66% gross margin, making Edge Medical the second surgical robotics company globally to reach half-year profitability, with cumulative case volumes surpassing 20,000 procedures across 300+ hospitals in 20+ countries. Pricing is not publicly disclosed and is structured through multi-year enterprise contracts varying by configuration and market.

Name

Edge Medical Co., Ltd.

Legal name

Shenzhen Edge Medical Co., Ltd.

Website

https://en.edgemed.cn

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Edge Medical is a Shenzhen-based surgical robotics company that designs and manufactures a '3-in-1' integrated surgical robot platform combining multi-port, single-port, and telesurgery capabilities, selling directly to leading hospitals and academic medical centers across 20+ countries, with primary applications in urology and other minimally invasive surgical disciplines.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Surgical robotics
• Minimally invasive surgery
• Robotic surgery systems
• Endoscopic surgical robots
• Telesurgery systems

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Robot Systems Sales: Sale of surgical robot systems (multi-port, single-port, bronchoscopy robots) to hospitals and medical institutions. Revenue is generated through commercial installation and system sales with supporting instruments and accessories.
2. Service and Technical Support: Ongoing clinical support, technical services, and training programs provided to hospital partners. Professional clinical support teams assist with installation, intraoperative support, and continuous training.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Edge Medical designs, develops, and manufactures surgical robotic systems for minimally invasive surgery. Its commercial product portfolio includes the Edge Multi-Port Endoscopic Surgical Robot, the Edge Single-Port Endoscopic Surgical Robot (China's first single-arm, single-port robot), the EdgeCloud Telesurgery System enabling cross-border remote surgery, and the Edge Bronchoscopic Robot (CP1000) for respiratory interventional procedures. These are sold to hospitals and medical institutions globally, accompanied by clinical support, training programs, and ongoing technical services.

Product overview

Edge Medical Co., Ltd. is a surgical robotics company that has developed a comprehensive product portfolio centered on its '3-in-1' integrated surgical robot platform. The portfolio consists of four core products: (1) Edge Multi-Port Endoscopic Surgical Robot for complex multi-port laparoscopic procedures; (2) Edge Single-Port Endoscopic Surgical Robot for ultra-minimally invasive single-incision surgery; (3) EdgeCloud Telesurgery System for cross-regional remote surgical collaboration; and (4) Edge Bronchoscopic Robot (CP1000) for respiratory interventional procedures. The '3-in-1' platform integrates multi-port, single-port, and telesurgery capabilities on a unified engineering architecture, enabling cross-procedure and cross-scenario systemic capabilities. Edge Medical is China's first company to receive NMPA registration approval for multi-port endoscopic surgical robot, single-port endoscopic surgical robot, and natural orifice surgical robot.

Differentiator

Problem solved

Functional benefit

Brands

• Edge® Multi-Port Surgical Robot: Multi-port endoscopic surgical robot approved for multiple surgical applications. China NMPA approved.
• Edge® Single-Port Surgical Robot
• EdgeCloud® Telesurgery System
• Edge® Bronchoscopic Surgical Robot

Products and services

• Edge Multi-Port Endoscopic Surgical Robot Multi-port laparoscopic surgical robot approved for urology, gynecology, general surgery, and thoracic surgery. Features high-definition 3D imaging, stable robotic arm control, and flexible instrument manipulation with over 30 specialized instruments. Sold to hospitals and medical institutions globally for minimally invasive surgery applications.
• Edge Single-Port Endoscopic Surgical Robot China's first single-arm, single-port endoscopic surgical robot. All instruments enter through a single trocar, achieving complex procedures through one incision with next-generation SuperArm instruments. Approved for gynecology, urology, general surgery, and thoracic surgery. Sold to hospitals for ultra-minimally invasive single-incision surgery applications.
• EdgeCloud Telesurgery System (TS02) Cloud-based remote surgery system enabling cross-regional and cross-border telesurgery. Supports dual-console collaborative operation, real-time mentorship, teleproctoring, and tele-education. Enables high-quality medical resources to transcend geographical boundaries from central cities to grassroots hospitals and across international borders.
• Edge Bronchoscopic Robot (CP1000) China's first dual-arm bronchoscopy robot designed for respiratory interventional diagnosis and treatment. Integrates high-precision robotic arms, intelligent navigation system, and intuitive visualization. Combines electromagnetic navigation, radial ultrasound, CBCT real-time positioning, and cryoablation technology for peripheral lung nodule diagnosis and treatment.

Quantifiable outcome

• Global surgical case volume surpassed 20,000 cases with applications spanning 300+ hospitals
• +7 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

Four partnerships are on record, tiered core, strategic and regional.

• IDS Medical SystemscoreChannel Partner/ Reseller/ DistributorIDS Medical Systems serves as Edge Medical's distribution partner for Southeast Asia, supporting market access and commercial expansion in the region. The partnership focuses on bringing affordable robotic surgery solutions to healthcare markets in Southeast Asia.
• ORSI AcademystrategicImplementation/ SI/ Consulting PartnerORSI Academy, one of the world's leading robotic surgery training centers based in Belgium, broadcasts live Edge Medical surgeries to surgeons across multiple countries, supporting international clinical training and education for the Edge platform.
• Oncorad Group, MoroccoregionalChannel Partner/ Reseller/ DistributorMorocco's top medical group Oncorad introduced Edge Medical's robot and completed the first batch of robotic surgeries in the northern region of the country, launching a new operate-and-teach model for training African surgeons.
• Chinese Medical Doctor Association (CUDA) Urology BranchstrategicStrategic or Co-development PartnerAnnual Meeting partnership for showcasing Edge Medical's 3-in-1 product matrix and participating in live surgery demonstrations at China's most influential urology academic gathering.

Scale indicators14 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Ronovo Surgical: Chinese surgical robotics startup developing laparoscopic robotic systems. Competes with Edge for Chinese clinical trial sites, hospital pilot installations, and eventual commercial deployments in China and select overseas markets.
• Vicarious Surgical: US-based surgical robotics developer focused on single-port abdominal surgery with a unique dual-arm architecture. Closely comparable to Edge's single-port platform in target procedure category and emerging-stage commercialization.
• Moon Surgical: European surgical robotics company developing the Maestro system for laparoscopic assistance. Competes with Edge in European hospital accounts and represents another capital-efficient entrant targeting the same soft-tissue surgical robotics category.

Direct peers

• Intuitive Surgical: The dominant global surgical robotics company (da Vinci platform) and Edge's primary benchmark. Both sell multi-port and single-port soft-tissue surgical robots to hospitals worldwide with similar capital-sales and recurring instrument/service business models.
• Microport MedBot (Shanghai Microport MedBot): Chinese surgical robotics competitor with the Toumai multi-port system and emerging single-port and orthopedic platforms. Direct peer competing for the same Chinese hospital customers and increasingly in emerging markets.
• Asensus Surgical: US-listed surgical robotics company (Senhance system) offering multi-port laparoscopic robots with haptic feedback. Competes with Edge in the same hospital minimally invasive surgery category with a similar capital-purchase business model.

Broad incumbents

• Medtronic: Broad incumbent medical device giant competing with the Hugo robotic surgery platform. Overlaps with Edge on multi-port laparoscopic robotics but operates a much larger diversified medtech portfolio targeting the same hospital customers.
• Stryker (Mako): Large medtech incumbent with the Mako orthopedic surgical robot. Not a direct soft-tissue competitor but a relevant peer in hospital surgical robotics, capital sales motion, and recurring instrument/service economics.
• Smith+Nephew (CORI): Global medtech incumbent with the CORI handheld robotics platform for orthopedics. Adjacent competitor for hospital surgical robotics capital budgets and a reference point for surgical robotics business models outside soft-tissue.
• Johnson & Johnson (MedTech): Large medtech incumbent developing the Ottava soft-tissue surgical robot. Competes with Edge for hospital robotic surgery budgets as part of a broader surgical and orthopedic device portfolio targeting the same surgical departments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/shenzhen-edge-medical

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edge Medical Co., Ltd.